This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
Downschedule decision on allergic rhinitis drugs
Related Posts
Research Roundup
Debbie Rigby rounds up the latest in research news Intranasal antihistamines and corticosteroids in allergic rhinitis A systematic review and meta-analysis of 151 studies has concluded that most intranasal medications are effective in improving allergic rhinitis symptoms and quality of life. In seasonal AR, azelastine-fluticasone, fluticasone furoate, and fluticasone propionate…
Fixing the schedule
Changes to diclofenac, fluticasone and cannabis schedules confirmed by TGA The TGA's Advisory Committee on Medicines Scheduling has confirmed earlier decisions to alter the scheduling of a number of widely used medicines. A provisional amendment to the entry for diclofenac, made earlier this year, was confirmed by the ACMS. The…
PBAC ‘has now seen sense’ on fluticasone
The controversial decision to restrict prescribing fluticasone propionate for young children has been reversed in a move welcomed by the Guild But families and pharmacists have been left without clear answers as to when they will be able to access the medicine via the Pharmaceutical Benefits Scheme, says one key…